影像学在直肠癌新辅助治疗疗效预测中的研究进展
Research Progress of Imaging Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer
DOI: 10.12677/acm.2025.151238, PDF,    国家自然科学基金支持
作者: 杨银蕊, 张彩霞, 普宗胜, 李振辉, 王关顺*：云南省肿瘤医院/昆明医科大学第三附属医院放射科，云南 昆明
关键词: 直肠癌；新辅助治疗；肿瘤；影像组学；深度学习；Rectal Cancer； Neoadjuvant Therapy； Tumor； Radiomics； Deep Learning
摘要: 目的：了解影像学在直肠癌新辅助治疗疗效预测中的研究进展。方法：检索近年来有关直肠癌新辅助治疗疗效预测的相关文献并进行综述。结果：讨论了对于影像学新技术在直肠癌疗效预测中的最新进展，并且评估了新辅助治疗对直肠癌疗效的常用成像方法及新技术的优点和缺点。结论：对于临床治疗而言，我们应该准确地利用各种影像学方法的优势，采用综合的方法来对直肠癌新辅助治疗疗效进行全方位、客观、准确的评估，为临床提供决策依据，最终提高直肠癌患者的总体生存期。
Abstract: Objective: To review the progress in imaging techniques for predicting the efficacy of neoadjuvant therapy in rectal cancer. Methods: A literature review was conducted on recent studies related to the prediction of neoadjuvant therapy efficacy in rectal cancer. Results: The latest advances in imaging technologies for assessing the efficacy of neoadjuvant therapy in rectal cancer were discussed. Additionally, common imaging methods and new technologies used to evaluate neoadjuvant treatment efficacy were assessed in terms of their advantages and limitations. Conclusion: For clinical practice, it is essential to accurately leverage the strengths of various imaging modalities. A comprehensive approach should be adopted to provide a thorough, objective, and precise evaluation of the efficacy of neoadjuvant therapy in rectal cancer, which will assist in clinical decision-making and ultimately improve the overall survival of rectal cancer patients.
文章引用：杨银蕊, 张彩霞, 普宗胜, 李振辉, 王关顺. 影像学在直肠癌新辅助治疗疗效预测中的研究进展[J]. 临床医学进展, 2025, 15(1): 1785-1794. https://doi.org/10.12677/acm.2025.151238

参考文献

[1] Wei, E.K., Giovannucci, E., Wu, K., Rosner, B., Fuchs, C.S., Willett, W.C., et al. (2003) Comparison of Risk Factors for Colon and Rectal Cancer. International Journal of Cancer, 108, 433-442. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Siegel, R.L., Miller, K.D., Goding Sauer, A., Fedewa, S.A., Butterly, L.F., Anderson, J.C., et al. (2020) Colorectal Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 145-164. [Google Scholar] [CrossRef] [PubMed]
[4] Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., et al. (2018) Cancer Incidence and Mortality Patterns in Europe: Estimates for 40 Countries and 25 Major Cancers in 2018. European Journal of Cancer, 103, 356-387. [Google Scholar] [CrossRef] [PubMed]
[5] Cercek, A., Roxburgh, C.S.D., Strombom, P., Smith, J.J., Temple, L.K.F., Nash, G.M., et al. (2018) Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncology, 4, e180071. [Google Scholar] [CrossRef] [PubMed]
[6] Bigness, A., Imanirad, I., Sahin, I.H., Xie, H., Frakes, J., Hoffe, S., et al. (2021) Locally Advanced Rectal Adenocarcinoma: Treatment Sequences, Intensification, and Rectal Organ Preservation. CA: A Cancer Journal for Clinicians, 71, 198-208. [Google Scholar] [CrossRef] [PubMed]
[7] Conroy, T., Bosset, J., Etienne, P., Rio, E., François, É., Mesgouez-Nebout, N., et al. (2021) Neoadjuvant Chemotherapy with FOLFIRINOX and Preoperative Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer (UNICANCER-PRODIGE 23): A Multicentre, Randomised, Open-Label, Phase 3 Trial. The Lancet Oncology, 22, 702-715. [Google Scholar] [CrossRef] [PubMed]
[8] Li, Y., Wang, J., Ma, X., Tan, L., Yan, Y., Xue, C., et al. (2016) A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. International Journal of Biological Sciences, 12, 1022-1031. [Google Scholar] [CrossRef] [PubMed]
[9] Zou, H., Yu, J., Wei, Y., Wu, J. and Xu, Q. (2018) Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectum Cancer: Texture Analysis of Dynamic Contrast‐Enhanced MRI. Journal of Magnetic Resonance Imaging, 49, 885-893. [Google Scholar] [CrossRef] [PubMed]
[10] Vandendorpe, B., Durot, C., Lebellec, L., Le Deley, M., Sylla, D., Bimbai, A., et al. (2019) Prognostic Value of the Texture Analysis Parameters of the Initial Computed Tomographic Scan for Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer. Radiotherapy and Oncology, 135, 153-160. [Google Scholar] [CrossRef] [PubMed]
[11] Dilek, O., Akkaya, H., Parlatan, C., Koseci, T., Tas, Z.A., Soker, G., et al. (2021) Can the Mesorectal Fat Tissue Volume Be Used as a Predictive Factor in Foreseeing the Response to Neoadjuvant Chemoradiotherapy in Rectum Cancer? A CT-Based Preliminary Study. Abdominal Radiology, 46, 2415-2422. [Google Scholar] [CrossRef] [PubMed]
[12] Olsen, A.S.F., Gundestrup, A.K., Kleif, J., Thanon, T. and Bertelsen, C.A. (2020) Accuracy of Preoperative Staging with Multidetector Computed Tomography in Colon Cancer. Colorectal Disease, 23, 680-688. [Google Scholar] [CrossRef] [PubMed]
[13] Joye, I., Deroose, C.M., Vandecaveye, V. and Haustermans, K. (2014) The Role of Diffusion-Weighted MRI and 18F-FDG PET/CT in the Prediction of Pathologic Complete Response after Radiochemotherapy for Rectal Cancer: A Systematic Review. Radiotherapy and Oncology, 113, 158-165. [Google Scholar] [CrossRef] [PubMed]
[14] Patel, U.B., Brown, G., Machado, I., Santos-Cores, J., Pericay, C., Ballesteros, E., et al. (2017) MRI Assessment and Outcomes in Patients Receiving Neoadjuvant Chemotherapy Only for Primary Rectal Cancer: Long-Term Results from the GEMCAD 0801 Trial. Annals of Oncology, 28, 344-353. [Google Scholar] [CrossRef] [PubMed]
[15] Beets-Tan, R., Beets, G., Vliegen, R., Kessels, A., Boven, H.V., Bruine, A.D., et al. (2001) Accuracy of Magnetic Resonance Imaging in Prediction of Tumour-Free Resection Margin in Rectal Cancer Surgery. The Lancet, 357, 497-504. [Google Scholar] [CrossRef] [PubMed]
[16] Gollub, M.J., Schwartz, L.H. and Akhurst, T. (2007) Update on Colorectal Cancer Imaging. Radiologic Clinics of North America, 45, 85-118. [Google Scholar] [CrossRef] [PubMed]
[17] Xiao, Y., Xu, D., Ju, H., Yang, C., Wang, L., Wang, J., et al. (2018) Application Value of Biplane Transrectal Ultrasonography Plus Ultrasonic Elastosonography and Contrast-Enhanced Ultrasonography in Preoperative T Staging after Neoadjuvant Chemoradiotherapy for Rectal Cancer. European Journal of Radiology, 104, 20-25. [Google Scholar] [CrossRef] [PubMed]
[18] Crimì, F., Capelli, G., Spolverato, G., Bao, Q.R., Florio, A., Milite Rossi, S., et al. (2020) MRI T2-Weighted Sequences-Based Texture Analysis (TA) as a Predictor of Response to Neoadjuvant Chemo-Radiotherapy (nCRT) in Patients with Locally Advanced Rectal Cancer (LARC). La Radiologia Medica, 125, 1216-1224. [Google Scholar] [CrossRef] [PubMed]
[19] Bakke, K.M., Hole, K.H., Dueland, S., Grøholt, K.K., Flatmark, K., Ree, A.H., et al. (2017) Diffusion-Weighted Magnetic Resonance Imaging of Rectal Cancer: Tumour Volume and Perfusion Fraction Predict Chemoradiotherapy Response and Survival. Acta Oncologica, 56, 813-818. [Google Scholar] [CrossRef] [PubMed]
[20] Cao, W., Li, B., Gong, J., Hu, M., Li, W., Pan, X., et al. (2020) Diffusion-Weighted Magnetic Resonance Imaging of Mucin Pools in Locally Advanced Rectal Mucinous Adenocarcinoma Predicts Tumor Response to Neoadjuvant Therapy. European Journal of Radiology, 125, Article 108890. [Google Scholar] [CrossRef] [PubMed]
[21] Napoletano, M., Mazzucca, D., Prosperi, E., Aisa, M.C., Lupattelli, M., Aristei, C., et al. (2019) Locally Advanced Rectal Cancer: Qualitative and Quantitative Evaluation of Diffusion-Weighted Magnetic Resonance Imaging in Restaging after Neoadjuvant Chemo-Radiotherapy. Abdominal Radiology, 44, 3664-3673. [Google Scholar] [CrossRef] [PubMed]
[22] Liang, C., Chen, M., Zhao, X., Yan, C., Mei, Y. and Xu, Y. (2019) Multiple Mathematical Models of Diffusion-Weighted Magnetic Resonance Imaging Combined with Prognostic Factors for Assessing the Response to Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Rectal Cancer. European Journal of Radiology, 110, 249-255. [Google Scholar] [CrossRef] [PubMed]
[23] Yang, L., Xia, C., Zhao, J., Zhou, X. and Wu, B. (2021) The Value of Intravoxel Incoherent Motion and Diffusion Kurtosis Imaging in the Assessment of Tumor Regression Grade and T Stages after Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. European Journal of Radiology, 136, Article 109504. [Google Scholar] [CrossRef] [PubMed]
[24] Uutela, A., Ovissi, A., Hakkarainen, A., Ristimäki, A., Lundbom, N., Kallio, R., et al. (2021) Treatment Response of Colorectal Cancer Liver Metastases to Neoadjuvant or Conversion Therapy: A Prospective Multicentre Follow-Up Study Using MRI, Diffusion-Weighted Imaging and 1H-MR Spectroscopy Compared with Histology (Subgroup in the RAXO Trial). ESMO Open, 6, Article 100208. [Google Scholar] [CrossRef] [PubMed]
[25] Nishie, A., Asayama, Y., Ishigami, K., Ushijima, Y., Takayama, Y., Okamoto, D., et al. (2018) Amide Proton Transfer Imaging to Predict Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Journal of Gastroenterology and Hepatology, 34, 140-146. [Google Scholar] [CrossRef] [PubMed]
[26] Li, N., Dou, L., Zhang, Y., Jin, J., Wang, G., Xiao, Q., et al. (2017) Use of Sequential Endorectal US to Predict the Tumor Response of Preoperative Chemoradiotherapy in Rectal Cancer. Gastrointestinal Endoscopy, 85, 669-674. [Google Scholar] [CrossRef] [PubMed]
[27] Maas, M., Lambregts, D.M.J., Nelemans, P.J., Heijnen, L.A., Martens, M.H., Leijtens, J.W.A., et al. (2015) Assessment of Clinical Complete Response after Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Annals of Surgical Oncology, 22, 3873-3880. [Google Scholar] [CrossRef] [PubMed]
[28] Tjalma, J.J.J., Koller, M., Linssen, M.D., Hartmans, E., de Jongh, S., Jorritsma-Smit, A., et al. (2019) Quantitative Fluorescence Endoscopy: An Innovative Endoscopy Approach to Evaluate Neoadjuvant Treatment Response in Locally Advanced Rectal Cancer. Gut, 69, 406-410. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, J., Zhan, W., Chang, C., Zhang, X., Jia, Y., Dong, Y., et al. (2014) Breast Lesions: Evaluation with Shear Wave Elastography, with Special Emphasis on the “Stiff Rim” Sign. Radiology, 272, 63-72. [Google Scholar] [CrossRef] [PubMed]
[30] Cong, Y., Fan, Z., Dai, Y., Zhang, Z. and Yan, K. (2020) Application Value of Shear Wave Elastography in the Evaluation of Tumor Downstaging for Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy. Journal of Ultrasound in Medicine, 40, 81-89. [Google Scholar] [CrossRef] [PubMed]
[31] Martin-Gonzalez, P., de Mariscal, E.G., Martino, M.E., Gordaliza, P.M., Peligros, I., Carreras, J.L., et al. (2020) Association of Visual and Quantitative Heterogeneity of 18F-FDG PET Images with Treatment Response in Locally Advanced Rectal Cancer: A Feasibility Study. PLOS ONE, 15, e0242597. [Google Scholar] [CrossRef] [PubMed]
[32] Karahan Şen, N.P., Aksu, A. and Kaya, G.Ç. (2020) Value of Volumetric and Textural Analysis in Predicting the Treatment Response in Patients with Locally Advanced Rectal Cancer. Annals of Nuclear Medicine, 34, 960-967. [Google Scholar] [CrossRef] [PubMed]
[33] Kong, J.C., Ryan, J., Akhurst, T., Ngan, S.Y., Michael, M., Tie, J., et al. (2021) The Predictive Value of PET/CT for Distant Recurrences in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Journal of Medical Imaging and Radiation Oncology, 65, 917-924. [Google Scholar] [CrossRef] [PubMed]
[34] Schurink, N.W., van Kranen, S.R., Berbee, M., van Elmpt, W., Bakers, F.C.H., Roberti, S., et al. (2021) Studying Local Tumour Heterogeneity on MRI and FDG-PET/CT to Predict Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer. European Radiology, 31, 7031-7038. [Google Scholar] [CrossRef] [PubMed]
[35] Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., et al. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. New England Journal of Medicine, 351, 1731-1740. [Google Scholar] [CrossRef] [PubMed]
[36] Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., et al. (2005) Prognostic Significance of Tumor Regression after Preoperative Chemoradiotherapy for Rectal Cancer. Journal of Clinical Oncology, 23, 8688-8696. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, Z., Jiang, X., Zhang, R., Yu, T., Liu, S. and Luo, Y. (2021) Radiomics Signature as a New Biomarker for Preoperative Prediction of Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer. Diagnostic and Interventional Radiology, 27, 308-314. [Google Scholar] [CrossRef] [PubMed]
[38] Wan, L., Peng, W., Zou, S., Ye, F., Geng, Y., Ouyang, H., et al. (2021) MRI-Based Delta-Radiomics Are Predictive of Pathological Complete Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Academic Radiology, 28, S95-S104. [Google Scholar] [CrossRef] [PubMed]
[39] Horvat, N., Veeraraghavan, H., Khan, M., Blazic, I., Zheng, J., Capanu, M., et al. (2018) MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy. Radiology, 287, 833-843. [Google Scholar] [CrossRef] [PubMed]
[40] Li, Z., Ma, X., Shen, F., Lu, H., Xia, Y. and Lu, J. (2021) Evaluating Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Using Various MRI-Based Radiomics Models. BMC Medical Imaging, 21, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[41] Giannini, V., Mazzetti, S., Bertotto, I., Chiarenza, C., Cauda, S., Delmastro, E., et al. (2019) Predicting Locally Advanced Rectal Cancer Response to Neoadjuvant Therapy with 18F-FDG PET and MRI Radiomics Features. European Journal of Nuclear Medicine and Molecular Imaging, 46, 878-888. [Google Scholar] [CrossRef] [PubMed]
[42] Shaish, H., Aukerman, A., Vanguri, R., Spinelli, A., Armenta, P., Jambawalikar, S., et al. (2020) Radiomics of MRI for Pretreatment Prediction of Pathologic Complete Response, Tumor Regression Grade, and Neoadjuvant Rectal Score in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiation: An International Multicenter Study. European Radiology, 30, 6263-6273. [Google Scholar] [CrossRef] [PubMed]
[43] Liu, X., Zhang, D., Liu, Z., Li, Z., Xie, P., Sun, K., et al. (2021) Deep Learning Radiomics-Based Prediction of Distant Metastasis in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Multicentre Study. eBioMedicine, 69, Article 103442. [Google Scholar] [CrossRef] [PubMed]
[44] Zhang, X., Wang, L., Zhu, H., Li, Z., Ye, M., Li, X., et al. (2020) Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. Radiology, 296, 56-64. [Google Scholar] [CrossRef] [PubMed]
[45] Jin, C., Yu, H., Ke, J., Ding, P., Yi, Y., Jiang, X., et al. (2021) Predicting Treatment Response from Longitudinal Images Using Multi-Task Deep Learning. Nature Communications, 12, Article No. 1851. [Google Scholar] [CrossRef] [PubMed]
[46] Nie, K., Shi, L., Chen, Q., Hu, X., Jabbour, S.K., Yue, N., et al. (2016) Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome Based on Radiomics of Multiparametric MRI. Clinical Cancer Research, 22, 5256-5264. [Google Scholar] [CrossRef] [PubMed]
[47] Feng, L., Liu, Z., Li, C., Li, Z., Lou, X., Shao, L., et al. (2022) Development and Validation of a Radiopathomics Model to Predict Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Multicentre Observational Study. The Lancet Digital Health, 4, e8-e17. [Google Scholar] [CrossRef] [PubMed]

为你推荐